Cargando…
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians
OBJECTIVE: The United States is in the fourth wave of the opioid epidemic marked by the increase in fentanyl and co‐occurring stimulant use related overdose deaths. Measures are needed to quickly diagnose opioid and stimulant use disorders, yet current traditional diagnostic assessments pose barrier...
Autores principales: | Di Paola, Angela, Farabee, David, Springer, Sandra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499189/ https://www.ncbi.nlm.nih.gov/pubmed/37711754 http://dx.doi.org/10.1176/appi.prcp.20230022 |
Ejemplares similares
-
The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023) -
Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment
por: Ling, Walter, et al.
Publicado: (2019) -
Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use Disorder
por: Lier, Audun J, et al.
Publicado: (2022) -
The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study
por: Saunders, Elizabeth C., et al.
Publicado: (2022) -
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine()
por: Uscher-Pines, Lori, et al.
Publicado: (2020)